Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $2.10 USD
Change Today 0.00 / 0.00%
Volume 0.0
BVX On Other Exchanges
As of 8:04 PM 07/28/15 All times are local (Market data is delayed by at least 15 minutes).

bovie medical corp (BVX) Snapshot

Previous Close
Day High
Day Low
52 Week High
08/20/14 - $4.57
52 Week Low
07/27/15 - $2.10
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for BOVIE MEDICAL CORP (BVX)

Related News

No related news articles were found.

bovie medical corp (BVX) Related Businessweek News

No Related Businessweek News Found

bovie medical corp (BVX) Details

Bovie Medical Corporation engages in developing, manufacturing, and marketing a range of electrosurgical products and technologies, as well as related medical products used in doctors’ offices, surgery centers, and hospitals worldwide. The company also develops J-Plasma, a patented plasma-based surgical tool that utilizes a helium ionization process to provide surgeons with greater precision, minimal invasiveness, and an absence of conductive currents during surgery. It leverages its expertise in the design, development, and manufacture of electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing agreements. The company’s electrosurgical products include desiccators, generators, electrodes, electrosurgical pencils, and various ancillary disposable products used during procedures in gynecology, urology, plastic surgery, dermatology, veterinary, and other surgical markets for the cutting and coagulation of tissue. In addition, it offers electrosurgical disposables comprising Resistick II, a proprietary coating applied to stainless steel that resist eschar during surgery; and disposable laparoscopic electrodes for use by physicians from a group of specialties, including gynecology, general surgery, and urology. Further, the company provides battery operated cauteries for precise hemostasis in ophthalmology; specialty lighting instruments for use in ophthalmology, as well as distributes specialty lighting instruments; and a nerve locator stimulator primarily used for identifying motor nerves in hand and facial reconstructive surgery. It markets its electrosurgical products and technologies through both private labels and own brands, such as Bovie, Aaron, IDS, and ICON to distributors worldwide. The company was formerly known as An-Con Genetics Inc. and changed its name to Bovie Medical Corporation in October 1998. Bovie Medical Corporation is headquartered in Clearwater, Florida.

152 Employees
Last Reported Date: 02/27/15

bovie medical corp (BVX) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: $525.5K
President, Chief Sales & Marketing Officer an...
Total Annual Compensation: $397.9K
Executive Chairman
Total Annual Compensation: $295.2K
Chief Commercialization Officer
Total Annual Compensation: $302.0K
Senior Vice President
Total Annual Compensation: $283.8K
Compensation as of Fiscal Year 2014.

bovie medical corp (BVX) Key Developments

Bovie Medical Corporation Announces Executive Changes

Bovie Medical Corporation announced that Peter L. Donato, Chief Financial Officer and Secretary of Bovie Medical Corporation, intends to resign from his service as Chief Financial Officer, Executive Vice President, Treasurer and Secretary of the Company on or about June 25, 2015. On June 15, 2015, the Board of Directors of the Company appointed Jay Ewers, currently the Controller of the Company, as the Interim Chief Financial Officer, Treasurer and Secretary of the Company effective upon Mr. Donato’s resignation. Mr. Ewers has more than 30 years of senior experience and has held financial executive positions in corporations ranging from early stage to high profile public companies with global operations in the medical equipment, manufacturing and semiconductor industries. He has extensive experience with Sarbanes Oxley, inventory management, Oracle modules and financial planning & analysis. Bovie Medical will engage an executive search firm to conduct a search for a permanent CFO.

Bovie Medical Corporation, Annual General Meeting, Jul 16, 2015

Bovie Medical Corporation, Annual General Meeting, Jul 16, 2015., at 14:00 US Eastern Standard Time. Location: offices of Ruskin Moscou Faltischek, P.C.. Agenda: To elect seven directors to the board of directors of the company to serve until the 2016 annual meeting of stockholders; to approve the 2015 Share Incentive Plan; to ratify Frazier & Deeter, LLC as independent registered public accounting firm for the company for the fiscal year ending December 31, 2015; to approve a non-binding advisory resolution supporting the compensation of its named executive officers; and to transact such other business that may properly come before the meeting.

Bovie Medical Corporation Hires Mark Charbonneau as J-Plasma Product Development Manager

Bovie Medical Corporation announced that it has hired Mark Charbonneau as J-Plasma Product Development Manager. Prior to joining the company, Mark was an engineering manager for Centrix and senior manufacturing engineer for Ventripoint Diagnostics. Mr. Charbonneau’s hire was effective May 18, 2015. He reports to Mr. Shawn Roman, Director of Research and Development.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BVX:US $2.10 USD 0.00

BVX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
IRIDEX Corp $7.03 USD 0.00
MGC Diagnostics Corp $5.39 USD 0.00
Misonix Inc $9.16 USD 0.00
Stereotaxis Inc $1.44 USD 0.00
Synergetics USA Inc $4.66 USD 0.00
View Industry Companies

Industry Analysis


Industry Average

Valuation BVX Industry Range
Price/Earnings 8.7x
Price/Sales 1.4x
Price/Book 1.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.2x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BOVIE MEDICAL CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at